Medical and Pharmaceutical

The company says the certification will help boost domestic sales and secure further licensing internationally

And the Supreme Court will debate fully decriminalizing cannabis cultivation for medical purposes

Researchers tested some of the cannabinoid's most promising medical properties in a lab setting

Health authorities are recommending patients not to inhale

After starting treatment with pot, average opioid consumption dropped by 27%

But experts say the official decree is 'legally fragile' and could be thrown out by the high court

The parliamentary group has until May 20 to submit a report to inform future policy

Patients First is a response to U.K. patients voicing frustrations over the quality of legal medical cannabis

The research will take place at the Icahn School of Medicine at Mount Sinai, New York

'Psychedelic-assisted therapy will be an integral part of mental wellness therapeutic models in the very near future,' says one of the program's coordinators

Extracts and cannabis with THC above 0.2% remain illegal

The firm says Canadian patients will get broader access to its products, as it continues to push for international growth

Upwards of 112,000 Albanians have weighed in on the question

It appeared Health Canada was increasing access to the substance, but recent events suggest otherwise

Patients are being encouraged to transfer to Mendo Cannabis

The study adds to a body of emerging research suggesting pot is effective in reducing opioid use

Patients' health-related quality of life typically improves across a broad spectrum of chronic conditions

Despite South Dakotans voting for cannabis reform in 2020, their governor and lawmakers have challenged the resulting laws

It appears the company will continue operations through its Agro Greens business in Saskatchewan

Most states only allow doctors to prescribe pot based on a list of qualifying conditions

Lawmakers and industry groups have called on the president to not veto the currently proposed bill

About 1.3M people in the UK have long Covid

Following the trial's approval from Health Canada, psychedelic practitioners can now apply to be research subjects

The new rules will facilitate safer access to substances like psilocybin, but many in need won't qualify, experts say

Recent regulatory amendments signal greater acceptance of cannabis as medicine in the country

Industry organizations say they've taken action against the new regulations

As of Jan. 1, up to 6M patients can look forward to significantly reduced costs and a simpler application process

It's unclear what will happen with the proposed regulatory framework

Most licences will be issued without a fixed end date

The Canadian firm has partnered with a subsidiary of US pharmaceutical firm Merger Group

Some study participants stopped using cannabis out of fear of potential harm to the fetus, while others stopped because of social stigma, guilt and health reasons

Initial deliveries have been made to local pharmacies with planned shipments for Germany and the UK

Olorinab is a CB2 receptor agonist in a Phase 2 trial for IBS

The firm will celebrate by ringing the opening bell at the stock exchange on Thursday

Compared to non-consumers, people who used cannabis 20 days a month were more likely to experience both extremes of sleep duration

The new facility will feature the firm's ketamine-assisted therapy program, as well as a range of health and lifestyle services

The company says it expects changes to Canadian law that will allow pharmacies to sell cannabis directly to patients

While THC can cause temporary dose-dependent psychotic symptoms, researchers note that some clinical findings suggest CBD has a different effect

Research funded by MindMed suggests some antidepressants can reduce the unwanted side effects of psychedelics

A developed industry could be worth £1.2 billion and create about 41,000 jobs